Maryse Delehedde

Maryse Delehedde

Auto-generated profile, based on publicly available information

Maryse Delehedde

Department of Molecular Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
SSS. Sarrazin
S. Sarrazin
EAE. Adam
E. Adam
MLM. Lyon
M. Lyon
FDF. Depontieu
F. Depontieu
VMV. Motte
V. Motte
MDM. Delehedde
M. Delehedde

1 December 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DBDavid Béchard
David Béchard
TGThibaut Gentina
Thibaut Gentina
MDMaryse Delehedde
Maryse Delehedde
ASArnaud Scherpereel
Arnaud Scherpereel
MLMalcolm Lyon
Malcolm Lyon
PLPhilippe Lassalle
Philippe Lassalle
Proteoglycans that modulate the activities of growth factors, chemokines, and coagulation factors regulate in turn the vascular endothelium with respect to processes such as inflammation, hemostasis, and angiogenesis. Endothelial cell-specific molecule-1 is mainly expressed by endothelial cells and regulated by pro-inflammatory cytokines (Lassalle, P., Molet, S., Janin, A., Heyden, J. V., Tavernier, J., Fiers, W., Devos, R., and Tonnel, A. B. (1996) J. Biol. Chem. 271, 20458–20464). We demonstrate that this molecule is secreted as a soluble dermatan sulfate (DS) proteoglycan. This proteoglycan represents the major form either secreted by cell lines or circulating in the human bloodstream. Because this proteoglycan is specifically secreted by endothelial cells, we propose to name it endocan. The glycosaminoglycan component of endocan consists of a single DS chain covalently attached to serine 137. Endocan dose-dependently increased the hepatocyte growth factor/scatter factor (HGF/SF)-mediated proliferation of human embryonic kidney cells, whereas the nonglycanated form of endocan did not. Moreover, DS chains purified from endocan mimicked the endocan-mediated increase of cell proliferation in the presence of HGF/SF. Overall, our results demonstrate that endocan is a novel soluble dermatan sulfate proteoglycan produced by endothelial cells. Endocan regulates HGF/SF-mediated mitogenic activity and may support the function of HGF/SF not only in embryogenesis and tissue repair after injury but also in tumor progression.

1 April 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DWDavid C. West
David C. West
CRChris G. Rees
Chris G. Rees
LDLaurence Duchesne
Laurence Duchesne
SPSusannah J. Patey
Susannah J. Patey
CTCarla J. Terry
Carla J. Terry
DFDavid Garth Fernig
David Garth Fernig
The hypothesis that neuropilin-1 (Npn-1) may interact with heparin-binding proteins other than vascular endothelial growth factor has been tested using an optical biosensor-based binding assay. The results show that fibroblast growth factor (FGF) 1, 2, 4, and 7, FGF receptor 1, hepatocyte growth factor/scatter factor (HGF/SF), FGF-binding protein, normal protease sensitive form of prion protein, antithrombin III, and Npn-1 itself are all able to interact with Npn-1 immobilized on the sensor surface. FGF-2, FGF-4, and HGF/SF are also shown to interact with Npn-1 in a solution assay. Moreover, these protein-protein interactions are dependent on the ionic strength of the medium and are inhibited by heparin, and the kinetics of binding of FGF-2, FGF-4 and HGF/SF to Npn-1 are characterized by fast association rate constants (270,000–1,600,000 m–1 s–1). These results suggest that Npn-1 possesses a “heparin” mimetic site that is able to interact at least in part through ionic bonding with the heparin binding site on many of the proteins studied. Npn-1 was also found to potentiate the growth stimulatory activity of FGF-2 on human umbilical vein endothelial cells, indicating that Npn-1 may not just bind but also regulate the activity of heparin-binding proteins.

1 January 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
OOOlga Ostrovsky
Olga Ostrovsky
BBBluma Berman
Bluma Berman
JGJohn Gallagher
John Gallagher
BMBarbara Mulloy
Barbara Mulloy
DFDavid Garth Fernig
David Garth Fernig
DRDina Ron
Dina Ron
Heparan sulfates (HS) play an important role in the control of cell growth and differentiation by virtue of their ability to modulate the activities of heparin-binding growth factors, an issue that is particularly well studied for fibroblast growth factors (FGFs). HS/heparin co-ordinate the interaction of FGFs with their receptors (FGFRs) and are thought to play a critical role in receptor dimerization. Biochemical and crystallographic studies, conducted mainly with FGF-2 or FGF-1 and FGF receptors 1 and 2, suggests that an octasaccharide is the minimal length required for FGF- and FGFR-induced dimerization and subsequent activation. In addition, 6-O-sulfate groups are thought to be essential for binding of HS to FGFR and for receptor dimerization. We show here that oligosaccharides shorter than 8 sugar units support activation of FGFR2 IIIb by FGF-1 and interaction of FGFR4 with FGF-1. In contrast, only relatively long oligosaccharides supported receptor binding and activation in the FGF-1·FGFR1 or FGF-7·FGFR2 IIIb setting. In addition, both 6-O- and 2-O-desulfated heparin activated FGF-1 signaling via FGFR2 IIIb, whereas neither one stimulated FGF-1 signaling via FGFR1 or FGF-7 via FGFR2 IIIb. These findings indicate that the structure of HS required for activating FGFs is dictated by the specific FGF and FGFR combination. These different requirements may reflect the differences in the mode by which a given FGFR interacts with the various FGFs.

23 December 2009 in Histopathology
Verified
Journal Article
Closed access
PDF file
XLXavier Leroy
Xavier Leroy
SASebastien Aubert
Sebastien Aubert
LZLaurent Zini
Laurent Zini
HFHelene Franquet
Helene Franquet
GKGwenola Kervoaze
Gwenola Kervoaze
PLPhilippe Lassalle
Philippe Lassalle

1 July 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SDSimon Descamps
Simon Descamps
XLXuefen Lebourhis
Xuefen Lebourhis
MDMaryse Delehedde
Maryse Delehedde
BBBénoni Boilly
Bénoni Boilly
Hubert HondermarckHubert Hondermarck
Hubert Hondermarck
We show here that nerve growth factor (NGF), the archetypal neurotrophic factor, is able to stimulate the proliferation of breast cancer cells (MCF-7 and MDA-MB-231 cell lines), although it is unable to stimulate growth of normal breast epithelial cells (NBEC). This stimulation induced cells in the G0 phase to reenter the cell cycle, as well as shortening cell cycle duration. Immunoblotting experiments revealed that both the two cancer cell lines and the NBEC express high affinity (p140(trk)) and low affinity (p75) NGF receptors. Inhibition of the NGF growth-promoting effect by the drugs K-252a and PD98059 indicated that activation of Trk-tyrosine kinase activity and the mitogen-activated protein kinase cascade are necessary to obtain the mitogenic effect. Activation of mitogen-activated protein kinase can be detected in breast cancer cells after 10 min of NGF stimulation, whereas no change was detected in NBEC. These results demonstrate that NGF is a mitogenic factor for human breast cancer cells and that it might constitute a new regulator of breast tumor growth.